Tyrosinase-mediated formation of a reactive quinone from the depigmenting agents, 4-tert-butylphenol and 4-tert-butylcatechol

Pigment Cell Research

Volumn 13, Issue 1, 2000, Pages 33-38

  Thörneby Andersson, Kirsten ^a   Sterner, Olov ^a   Hansson, Christer ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

Chemical leukoderma; Glutathione; Melanocyte; Pigmentation; Quinone

Indexed keywords

ANTIOXIDANT; BUTYLPHEN; CATECHOL DERIVATIVE; CYSTEINE; GLUTATHIONE; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MONOPHENOL MONOOXYGENASE; PHENOL DERIVATIVE; PIGMENT; QUINONE DERIVATIVE; TERT BUTYLCATECHOL; TERT-BUTYLCATECHOL;

AGARICALES; ARTICLE; CELL CULTURE; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MELANOCYTE; MELANOMA; METABOLISM; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; OXIDATION REDUCTION REACTION; PIGMENTATION;

AGARICALES; ANTIOXIDANTS; CATECHOLS; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; GLUTATHIONE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASES; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MELANOCYTES; MELANOMA; MONOPHENOL MONOOXYGENASE; OXIDATION-REDUCTION; PHENOLS; PIGMENTATION; PIGMENTS, BIOLOGICAL; QUINONES; TUMOR CELLS, CULTURED;

AGARICALES;

EID: 0343239102     PISSN: 08935785     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0749.2000.130107.x     Document Type: Article

References (30)

1. Ortonne JP, Mosher DB, Fitzpatrick TB. Chemical hypomelanoses. In: Vitiligo and Other Hypomelanoses of Hair and Skin. New York: Plenum; 1983. pp. 479-508
2. Fisher AA. Differential diagnosis of contact leukoderma and idiopathic vitiligo: part I. Cutis 1994;53:158
3. Cummings MP, Nordlund JJ. Chemical leukoderma: fact or fancy. Am J Cont Derm 1995;6:122-127
4. McCarty LP. Chemical agents that cause depigmentation. In: Marzulli FN, Maibach HI. Dermatotoxicology, 5th edn. Washington: Taylor & Francis; 1996. pp. 275-282
5. Taylor JS, Maibach HI, Fisher AA, Bergfeld WF. Contact leukoderma associated with the use of hair colours. Cutis 1993;52:273-280
6. Wick MM. An experimental approach to chemotherapy of melanoma. J Invest Derm 1980;74:63-65
7. Ito Y, Jimbow K, Ito S. Depigmentation of black guinea pig skin by topical application of cysteaminylphenols, cysteinylphenol, and related compounds. J Invest Derm 1987;88:77-82
8. Naish-Byfield S, Cooksey CJ, Latter AM, Johnson CI, Riley PA. In vitro assessment of the structure-activity relationship of tyrosinase-dependent cytotoxicity of a series of substituted phenols. Melanoma Res 1991;1:273-287
9. Riley PA, Cooksey CJ, Johnson CI, Land EJ, Latter AM, Ramsden CA. Melanogenesis-targeted anti-melanoma pro-drug cytotoxicity of tyrosinase-generated ortho-quinones in a model screening system. Eur J Cancer 1997;33:135-143
10. Prota G. Melanin and Melanogenesis. San Diego: Academic Press: 1992
11. Cooksey CJ, Jimbow K, Land EJ, Riley PA. Reactivity of orthoquinones involved in tyrosinase-dependent cytotoxicity: differences between alkylthio- and alkoxy-substituents. Melanoma Res 1992;2:283-293
12. Menter JM, Etemadi AA, Chapman W, Hollins TD, Willis I. In vivo depigmentation by hydroxybenzene derivatives. Melanoma Res 1993;3:443-449
13. Hansson C. Electrochemical synthesis of cysteinyldopas. Experientia 1981;37:1253-1254
14. Teuber H-J, Staiger G. Reaktionen mit Nitrosodisulfonat. VIII. Mitteil.: ortho-Benzochinone und Phenazine. Chem Ber 1955;88:802-827
15. Gagliardi L, Cimorelli A, Cavazzuttti G, Montanarella L, Tonelli D. Determination of 4-tert-butylphenol and 4-tert-butylcatechol in cosmetic products by reversed-phase high-performance liquid chromatography. J Chromatogr 1989;466:433-437
16. Hansson C, Agrup G, Rorsman H, Rosengren A-M, Rosengren E, Edholm L-E. Analysis of cysteinyldopas. dopa, dopamine, noradrenaline and adrenaline in serum and urine using high performance liquid chromatography and electrochemical detection. J Chrom Biomed Appl 1979;162:7-22
17. Karg E, Odh G, Rosengren E, Wittbjer A, Rorsman H. Melanin-related biochemistry of IGR 1 human melanoma cells. Melanoma Res 1991;1:5-13
18. Byers LD. Glyceraldehyde-3-phosphate dehydrogenase from yeast. Meth Enzymol 1982;89:326-335
19. Jime'nez M, Garci'a-Carmona F. Hydrogen peroxide-dependent 4-t-butylphenol hydroxylation by tyrosinase - a new catalytic activity. Biochim Biophys Acta 1996;1297:33-39
20. Bleehen SS. The treatment of hypermelanosis with 4-isopropyl-catechol. Br J Derm 1976;94:687-694
21. Passi S, Picardo M, Nazzaro-Porro M. Comparative cytotoxicity of phenols in vitro. Biochem J 1987;245:537-542
22. Picardo M, Passi S, Nazzaro-Porro M, Breathnach A, Zompetta C, Faggioni A, Riley P. Mechanism of antitumoral activity of catechols in culture. Biochem Pharmacol 1987;36:417-425
23. Usami Y, Landau AB, Fukuyama K, Gellin GA. Inhibition of tyrosinase activity by 4-tert-butylcatechol and other depigmenting agents. J Tox Environ Health 1980;6:559-567
24. Rorsman H, Agrup G, Hansson C, Rosengren E. Biochemical recorders of malignant melanoma. In: MacKie RM. Pigment Cell. Basel, Vol. 6: Karger: 1983. pp. 93-115
25. Agrup G, Hansson C, Rorsman H, Rosengren E. The effect of cysteine on oxidation of tyrosine, dopa and cysteinyldopas. Arch Dermatol Res 1982;272:103-115
26. Carstam R, Hansson C, Lindbladh C, Rorsman H, Rosengren E. Dopaquinone addition products in cultured human melanoma cells. Acta Derm Venereol (Stockh) 1987;67:100-105
27. Sakai K, Hasumi K, Endo A. Inactivation of rabbit muscle glyceraldehyde-3-phosphate dehydrogenase by koningic acid. Biochim Biophys Acta 1988;952:297-303
28. Sies H, Brigelius R, Akerboom TPM. Intrahepatic glutathione status. In: Larsson A, Orrenius S, Holmgren A, Mannervik B. Functions of Glutathione: Biochemical, Physiological, Toxicological, and Clinical Aspects. New York: Raven Press; 1983. pp. 51-64
29. Hwang C, Sinskey AJ, Lodish HF. Oxidized redox state of glutathione in the endoplasmic reticulum. Science 1992;257:1496-1502
30. Wick MM, Fitzgerald G. Inhibition of reverse transcriptase by tyrosinase generated quinones related to levodopa and dopamine. Chem Biol Interact 1981;38:99-107